← SynDRA
PFK-015
SynDRA canonical compound SYN1957473 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
| Primary target(s) | PFKFB3 |
| Mechanism of action | phosphofructokinase inhibitor |
All known targets
Mechanisms of action (all sources)
- phosphofructokinase inhibitor
- PFKFB3 ANTAGONIST
Cross-references
Synonyms
- PFKFB3 inhibitors (cancer), Advanced Cancer Therapeutics
- PFKFB3 inhibitors (cancer), University of Louisville
- 3-PO
- 6-phosphofructo-2-kinase inhibitors (cancer), University of Louisville
- 3PO
- 3-(3-pyridinyl)-1-(4-pyridinyl)-2-propen-1-one
- (E)-3PO
- CHEMBL3105848
- (E)-3-pyridin-3-yl-1-pyridin-4-ylprop-2-en-1-one
- (E)-3-(Pyridin-3-yl)-1-(pyridin-4-yl)prop-2-en-1-one
- SCHEMBL196639
- (E)-3PO;3PO
- CHEBI:144367
- BCP34641
- ZINC3997313
- BDBM50445948
- s7639
- 3PO, >=98% (HPLC)
- AKOS025142053
- CCG-266648
- CS-5491
- SB17190
- NCGC00386709-03
- AS-55969
- HY-19824
- AB00079158-01
- SR-01000203323
- SR-01000203323-1
- 2-Propen-1-one, 3-(3-pyridinyl)-1-(4-pyridinyl)-
- 3-(pyridin-3-yl)-1-(pyridin-4-yl)prop-2-en-1-one
- (2E)-3-(3-pyridinyl)-1-(4-pyridinyl)-2-propen-1-one
- (E)-3-pyridin-3-yl-1-pyridin-4-ylprop-2-en-1-one (3PO)
- (2E)-3-(PYRIDIN-3-YL)-1-(PYRIDIN-4-YL)PROP-2-EN-1-ONE
Look up PFK-015 in the interactive SynDRA portal →